{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:02:15Z","timestamp":1760781735062},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gene"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.gene.2012.07.051","type":"journal-article","created":{"date-parts":[[2012,8,8]],"date-time":"2012-08-08T15:57:03Z","timestamp":1344441423000},"page":"438-443","source":"Crossref","is-referenced-by-count":14,"title":["1\u03b1,25-Dihydroxyvitamin D3 and rosiglitazone synergistically enhance osteoblast-mediated mineralization"],"prefix":"10.1016","volume":"512","author":[{"given":"V.J.","family":"Woeckel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Bruedigam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Koedam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.C.J.","family":"van der Eerden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.P.T.M.","family":"van Leeuwen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.gene.2012.07.051_bb0005","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1359\/jbmr.090832","article-title":"Phosphorylation-dependent inhibition of mineralization by osteopontin ASARM peptides is regulated by PHEX cleavage","volume":"25","author":"Addison","year":"2010","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.gene.2012.07.051_bb0010","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1172\/JCI200419900","article-title":"PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors","volume":"113","author":"Akune","year":"2004","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.gene.2012.07.051_bb0015","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.bone.2007.02.024","article-title":"Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1 alpha,25-dihydroxyvitamin D3","volume":"40","author":"Atkins","year":"2007","journal-title":"Bone"},{"issue":"3\u20135","key":"10.1016\/j.gene.2012.07.051_bb0020","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jsbmb.2006.12.054","article-title":"1,25-Dihydroxyvitamin D3\/VDR-mediated induction of FGF23 as well as transcriptional control of other bone anabolic and catabolic genes that orchestrate the regulation of phosphate and calcium mineral metabolism","volume":"103","author":"Barthel","year":"2007","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"2","key":"10.1016\/j.gene.2012.07.051_bb0025","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0169-6009(08)80225-5","article-title":"Osteopontin-hydroxyapatite interactions in vitro: inhibition of hydroxyapatite formation and growth in a gelatin-gel","volume":"22","author":"Boskey","year":"1993","journal-title":"Bone Miner."},{"issue":"2","key":"10.1016\/j.gene.2012.07.051_bb0030","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00223-001-1121-z","article-title":"Osteopontin deficiency increases mineral content and mineral crystallinity in mouse bone","volume":"71","author":"Boskey","year":"2002","journal-title":"Calcif. Tissue Int."},{"issue":"11","key":"10.1016\/j.gene.2012.07.051_bb0045","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/j.febslet.2008.04.012","article-title":"Evidence for multiple peroxisome proliferator-activated receptor gamma transcripts in bone: fine-tuning by hormonal regulation and mRNA stability","volume":"582","author":"Bruedigam","year":"2008","journal-title":"FEBS Lett."},{"issue":"5","key":"10.1016\/j.gene.2012.07.051_bb0040","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/stem.405","article-title":"A new concept underlying stem cell lineage skewing that explains the detrimental effects of thiazolidinediones on bone","volume":"28","author":"Bruedigam","year":"2010","journal-title":"Stem Cells"},{"issue":"5","key":"10.1016\/j.gene.2012.07.051_bb0035","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.yjmcc.2011.07.020","article-title":"Opposing actions of rosiglitazone and resveratrol on mineralization in human vascular smooth muscle cells","volume":"51","author":"Bruedigam","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"3","key":"10.1016\/j.gene.2012.07.051_bb0050","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s12020-010-9426-1","article-title":"Elevated vitamin D status in postmenopausal women on thiazolidinediones for type 2 diabetes","volume":"39","author":"Chakreeyarat","year":"2011","journal-title":"Endocrine"},{"issue":"3","key":"10.1016\/j.gene.2012.07.051_bb0055","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1349-7006.1993.tb02869.x","article-title":"Establishment and characterization of a simian virus 40-immortalized osteoblastic cell line from normal human bone","volume":"84","author":"Chiba","year":"1993","journal-title":"Jpn. J. Cancer Res."},{"issue":"4","key":"10.1016\/j.gene.2012.07.051_bb0060","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/jcb.10423","article-title":"New insights into the mechanisms of vitamin D action","volume":"88","author":"Christakos","year":"2003","journal-title":"J. Cell. Biochem."},{"issue":"6","key":"10.1016\/j.gene.2012.07.051_bb0070","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/BF00369216","article-title":"Insulin increases histomorphometric indices of bone formation In vivo","volume":"59","author":"Cornish","year":"1996","journal-title":"Calcif. Tissue Int."},{"issue":"4 Pt 1","key":"10.1016\/j.gene.2012.07.051_bb0065","first-page":"E694","article-title":"Systemic administration of amylin increases bone mass, linear growth, and adiposity in adult male mice","volume":"275","author":"Cornish","year":"1998","journal-title":"Am. J. Physiol."},{"issue":"6590","key":"10.1016\/j.gene.2012.07.051_bb0075","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/382448a0","article-title":"Increased bone formation in osteocalcin-deficient mice","volume":"382","author":"Ducy","year":"1996","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.gene.2012.07.051_bb0080","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jmb.2005.03.060","article-title":"The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor","volume":"349","author":"Dunlop","year":"2005","journal-title":"J. Mol. Biol."},{"issue":"1\u20132","key":"10.1016\/j.gene.2012.07.051_bb0085","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.mce.2005.11.034","article-title":"The essential role of glucocorticoids for proper human osteoblast differentiation and matrix mineralization","volume":"248","author":"Eijken","year":"2006","journal-title":"Mol. Cell. Endocrinol."},{"issue":"11","key":"10.1016\/j.gene.2012.07.051_bb0090","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1096\/fj.07-8080com","article-title":"The activin A-follistatin system: potent regulator of human extracellular matrix mineralization","volume":"21","author":"Eijken","year":"2007","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.gene.2012.07.051_bb0095","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/j.1582-4934.2009.00751.x","article-title":"Inhibition of fatty acid biosynthesis prevents adipocyte lipotoxicity on human osteoblasts in vitro","volume":"14","author":"Elbaz","year":"2010","journal-title":"J. Cell. Mol. Med."},{"issue":"4","key":"10.1016\/j.gene.2012.07.051_bb0100","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1210\/jc.2006-2646","article-title":"The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trial","volume":"92","author":"Grey","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"Pt 1","key":"10.1016\/j.gene.2012.07.051_bb0105","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1042\/bj3170059","article-title":"Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins","volume":"317","author":"Hunter","year":"1996","journal-title":"Biochem. J."},{"issue":"26","key":"10.1016\/j.gene.2012.07.051_bb0110","doi-asserted-by":"crossref","first-page":"23270","DOI":"10.1074\/jbc.M211610200","article-title":"Activation of peroxisome proliferator-activated receptor-gamma inhibits the Runx2-mediated transcription of osteocalcin in osteoblasts","volume":"278","author":"Jeon","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"1\u20132","key":"10.1016\/j.gene.2012.07.051_bb0115","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.tox.2007.02.005","article-title":"Role of mitogen-activated protein kinase (MAPK) in troglitazone-induced osteoblastic cell death","volume":"234","author":"Jung","year":"2007","journal-title":"Toxicology"},{"issue":"1","key":"10.1016\/j.gene.2012.07.051_bb0120","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0022-2143(03)00058-1","article-title":"Activation of peroxisome proliferator-activated receptor-gamma inhibits differentiation of preosteoblasts","volume":"142","author":"Khan","year":"2003","journal-title":"J. Lab. Clin. Med."},{"issue":"2","key":"10.1016\/j.gene.2012.07.051_bb0125","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.taap.2006.03.001","article-title":"Activation of peroxisome proliferator-activated receptor-gamma (PPARgamma) induces cell death through MAPK-dependent mechanism in osteoblastic cells","volume":"215","author":"Kim","year":"2006","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"3","key":"10.1016\/j.gene.2012.07.051_bb0135","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7","article-title":"Inhibition of Osf2\/Cbfa1 expression and terminal osteoblast differentiation by PPARgamma2","volume":"74","author":"Lecka-Czernik","year":"1999","journal-title":"J. Cell. Biochem."},{"issue":"6","key":"10.1016\/j.gene.2012.07.051_bb0140","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1210\/en.143.6.2376","article-title":"Divergent effects of selective peroxisome proliferator-activated receptor-gamma 2 ligands on adipocyte versus osteoblast differentiation","volume":"143","author":"Lecka-Czernik","year":"2002","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.gene.2012.07.051_bb0130","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1210\/en.2006-1121","article-title":"Activation of peroxisome proliferator-activated receptor gamma (PPARgamma) by rosiglitazone suppresses components of the insulin-like growth factor regulatory system in vitro and in vivo","volume":"148","author":"Lecka-Czernik","year":"2007","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.gene.2012.07.051_bb0145","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1073\/pnas.86.4.1143","article-title":"Structure of the rat osteocalcin gene and regulation of vitamin D-dependent expression","volume":"86","author":"Lian","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.gene.2012.07.051_bb0150","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/(SICI)1097-4644(19980101)68:1<31::AID-JCB4>3.0.CO;2-X","article-title":"Apoptosis during bone-like tissue development in vitro","volume":"68","author":"Lynch","year":"1998","journal-title":"J. Cell. Biochem."},{"issue":"6","key":"10.1016\/j.gene.2012.07.051_bb0155","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s00223-001-1039-5","article-title":"A highly potent 26,27-hexafluoro-1a,25-dihydroxyvitamin D3 on calcification in SV40-transformed human fetal osteoblastic cells","volume":"70","author":"Miyahara","year":"2002","journal-title":"Calcif. Tissue Int."},{"issue":"4","key":"10.1016\/j.gene.2012.07.051_bb0160","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/jcp.22841","article-title":"Decreased oxygen tension lowers reactive oxygen species and apoptosis and inhibits osteoblast matrix mineralization through changes in early osteoblast differentiation","volume":"227","author":"Nicolaije","year":"2012","journal-title":"J. Cell. Physiol."},{"issue":"5","key":"10.1016\/j.gene.2012.07.051_bb0165","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1021\/bi00353a035","article-title":"Inhibition of hydroxyapatite crystal growth by bone-specific and other calcium-binding proteins","volume":"25","author":"Romberg","year":"1986","journal-title":"Biochemistry"},{"issue":"6","key":"10.1016\/j.gene.2012.07.051_bb0170","first-page":"1604","article-title":"Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy","volume":"60","author":"Rubin","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.gene.2012.07.051_bb0175","first-page":"119","article-title":"Metabolism of vitamin D3 by cytochromes P450","volume":"10","author":"Sakaki","year":"2005","journal-title":"Front. Biosci."},{"issue":"9","key":"10.1016\/j.gene.2012.07.051_bb0180","first-page":"3647","article-title":"Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells","volume":"29","author":"Sertznig","year":"2009","journal-title":"Anticancer Res."},{"issue":"4","key":"10.1016\/j.gene.2012.07.051_bb0185","doi-asserted-by":"crossref","first-page":"232","DOI":"10.4161\/derm.1.4.9629","article-title":"Activation of vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling pathways through 1,25(OH)(2)D(3) in melanoma cell lines and other skin-derived cell lines","volume":"1","author":"Sertznig","year":"2009","journal-title":"Dermatoendocrinology"},{"issue":"49","key":"10.1016\/j.gene.2012.07.051_bb0190","doi-asserted-by":"crossref","first-page":"40589","DOI":"10.1074\/jbc.M504166200","article-title":"The vitamin D receptor, Runx2, and the Notch signaling pathway cooperate in the transcriptional regulation of osteopontin","volume":"280","author":"Shen","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.gene.2012.07.051_bb0195","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1677\/joe.1.05723","article-title":"Rosiglitazone impacts negatively on bone by promoting osteoblast\/osteocyte apoptosis","volume":"183","author":"Soroceanu","year":"2004","journal-title":"J. Endocrinol."},{"issue":"13","key":"10.1016\/j.gene.2012.07.051_bb0200","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1096\/fj.06-6374fje","article-title":"Evidence for auto\/paracrine actions of vitamin D in bone: 1alpha-hydroxylase expression and activity in human bone cells","volume":"20","author":"van Driel","year":"2006","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.gene.2012.07.051_bb0205","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/jcb.20875","article-title":"Evidence that both 1alpha,25-dihydroxyvitamin D3 and 24-hydroxylated D3 enhance human osteoblast differentiation and mineralization","volume":"99","author":"van Driel","year":"2006","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.gene.2012.07.051_bb0210","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/nar\/30.1.169","article-title":"Genew: the human gene nomenclature database","volume":"30","author":"Wain","year":"2002","journal-title":"Nucleic Acids Res."},{"issue":"12","key":"10.1016\/j.gene.2012.07.051_bb0215","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1038\/nm1672","article-title":"PPAR-gamma regulates osteoclastogenesis in mice","volume":"13","author":"Wan","year":"2007","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.gene.2012.07.051_bb0220","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s007740300026","article-title":"Decrease in serum leptin by troglitazone is associated with preventing bone loss in type 2 diabetic patients","volume":"21","author":"Watanabe","year":"2003","journal-title":"J. Bone Miner. Metab."},{"issue":"2","key":"10.1016\/j.gene.2012.07.051_bb0230","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/jcp.22244","article-title":"1alpha,25-(OH)2D3 acts in the early phase of osteoblast differentiation to enhance mineralization via accelerated production of mature matrix vesicles","volume":"225","author":"Woeckel","year":"2010","journal-title":"J. Cell. Physiol."},{"issue":"3\u20135","key":"10.1016\/j.gene.2012.07.051_bb0235","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jsbmb.2006.11.002","article-title":"1alpha,25(OH)2-vitamin D3 membrane-initiated calcium signaling modulates exocytosis and cell survival","volume":"103","author":"Xiaoyu","year":"2007","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"8","key":"10.1016\/j.gene.2012.07.051_bb0240","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1359\/jbmr.080326","article-title":"Vitamin D receptor-dependent 1 alpha,25(OH)2 vitamin D3-induced anti-apoptotic PI3K\/AKT signaling in osteoblasts","volume":"23","author":"Zhang","year":"2008","journal-title":"J. Bone Miner. Res."}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037811191200902X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037811191200902X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T08:06:20Z","timestamp":1714291580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037811191200902X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S037811191200902X"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2012.07.051","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}